Poziotinib Shows Promise for Rare Lung Cancer [News in Brief]

Good responses seen in patients with exon 20 mutations, for which approved EGFR inhibitors are largely ineffective.

from Cancer via ola Kala on Inoreader http://ift.tt/2jcjBwH
via IFTTT